Metagenomi, Inc. Common Stock (MGX) Live Share Price, Invest From India

Metagenomi, Inc. Common Stock Stock Performance

as on April 25, 2026 at 6:59 am IST

Day's Low
$1.42
Day's Price Range
$1.50
$1.50
5.33%
Downside
52 Week's Low
52 Week's High
$1.25
52-Week Price Range
$3.95
$1.50
16.67%
Downside
163.33%
Upside

Metagenomi, Inc. Common Stock share price movements today

Previous Close: $1.43
Open: $1.47
Volume: 666.8K
Day's Low - High: $1.42 - $1.50
52 Week Low - High: $1.25 - $3.95

Metagenomi, Inc. Common Stock Historical Returns

1 Month Return: + 7.91 %
3 Month Return: -11.24 %
1 Year Return: -13.79 %
3 Year Return: 0 %
5 Year Return: 0 %

Metagenomi, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Metagenomi, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$56.4M

EPS (TTM)

-2.3375

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-90.7M

Revenue (TTM)

25.2M

Profit Margin

0.00%

Return On Equity TTM

-44.67%

Metagenomi, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Metagenomi, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Metagenomi, Inc. Common Stock	BUY	$56.4M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.8B	123.48%	131.7	8.45%
Vertex Pharmaceuticals Inc	BUY	$109.4B	97.47%	28.09	32.94%
BeiGene, Ltd.	NA	$33.4B	NA	121.78	5.37%
Regeneron Pharmaceuticals Inc	BUY	$79.5B	53.81%	18.11	31.41%

Stock Returns calculator for Metagenomi, Inc. Common Stock Stock including INR - Dollar returns

The Metagenomi, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Metagenomi, Inc. Common Stock investment value today

Current value as on today

₹95,127

Returns

-₹4,873

(-4.87%)

Returns from Metagenomi, Inc. Common Stock Stock

-₹13,793 (-13.79%)

Dollar Impact

₹8,920 (+8.92%)

Analyst Recommendation on Metagenomi, Inc. Common Stock Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Metagenomi, Inc. Common Stock. Average target price of $9.33

Metagenomi, Inc. Common Stock Share Price Target

Get share price movements and forecasts by analysts on Metagenomi, Inc. Common Stock.

What analysts predicted

83.92%UPSIDE

Target Price

$9.33

Current Price

$1.5

Analyzed by

10 Analysts

Target

$9.33

Metagenomi, Inc. Common Stock target price $9.33, a slight upside of 83.92% compared to current price of $1.5. According to 10 analysts rating.

Metagenomi, Inc. Common Stock Stock’s Investor Sentiment and Interest

Search interest for Metagenomi, Inc. Common Stock Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 27, 2026 to April 26, 2026

Change:-32% versus previous 30 day period

Metagenomi, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	12	12	11	20	11	9	4	8	8	3
Gross Profit	-14	-12	-20	20	11	9	4	-13	7	2
Operating Income	-22	-20	-29	-16	-22	-20	-27	-20	-22	-24
EBITDA	-21	-18	-27	-15	-21	-19	-26	-19	-19	-23
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	1	1	1	1	1	1	1	1	1	1
Income Before Tax	-18	-16	-25	-12	-20	-24	-24	-19	-20	-22
Income Tax Expense	1	2	-3	-2	-2	-1	0	0	0	0
Net Income	-19	-19	-25	-10	-18	-23	-25	-19	-20	-22
Net Profit Margin	-160.32%	-155.61%	-225.36%	-53.67%	-163.04%	-243.37%	-606.71%	-233.85%	-235.51%	-576.02%

Metagenomi, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	0	17	44	52	25
Gross Profit	0	15	-49	52	19
Operating Income	-23	-44	-78	-88	-96
EBITDA	-20	-39	-74	-83	-90
Interest Expense	0	0	-	-	-
Depreciation	0	1	4	5	5
Income Before Tax	-21	-41	-60	-83	-87
Income Tax Expense	0	2	8	-5	0
Net Income	-21	-43	-68	-78	-87
Net Profit Margin	-8823.87%	-253.45%	-152.50%	-149.26%	-348.54%

Metagenomi, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-19	-25	-10	-18	-23	-25	-19	-20	-22
Operating Cash Flow	-20	-29	-26	-26	-26	-22	-21	-21	-23
Investing Cash Flow	60	-94	-13	-8	28	24	19	27	32
Financing Cash Flow	-1	86	-2	0	-	0	0	0	0
Change in Cash	38	-38	-41	-36	2	1	-2	5	8

Metagenomi, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	-43	-68	-78	-87
Operating Cash Flow	29	-91	-109	-88
Investing Cash Flow	-122	45	-88	103
Financing Cash Flow	239	1	84	0
Change in Cash	147	-44	-113	14

Insights on Metagenomi, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 24.7% return, outperforming this stock by 38.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -19.90M → -22.52M (in $), with an average decrease of 6.5% per quarter
NEGATIVE IMPACT
Price Dip
In the last 6 months, MGX stock has moved down by -48.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 8.65M → 3.91M (in $), with an average decrease of 54.8% per quarter

About Metagenomi, Inc. Common Stock

Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for the treatment of hyper triglyceridemia, transthyretin (TTR) for transthyretin amyloidosis, angiotensinogen (AGT) for refractory hypertension, and other programs. The company was formerly known as Metagenomi, Inc. and changed its name to Metagenomi Therapeutics, Inc. in January 2026. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.

Organisation	Metagenomi, Inc. Common Stock
Headquarters	5959 Horton Street, Emeryville, CA, United States, 94608
Industry	Biotechnology
CEO	Dr. Jian Irish M.B.A., Ph.D.
E-voting on shares	Click here to vote

Key Management of Metagenomi, Inc. Common Stock

Name	Title
Dr. Alan Brooks Ph.D.	Senior Vice President of Research
Ms. Katalin Kauser M.D., Ph.D.	Senior Vice President of Translational Biology
Dr. Jian Irish M.B.A., Ph.D.	CEO, President & Director
Dr. Brian Charles Thomas Ph.D.	Co-Founder & Director
Ms. Pamela M. Wapnick M.B.A.	Chief Financial Officer
Dr. Joseph Knowles M.D.	Co-Founder & Member of Scientific Advisory Board
Mr. Mark Leonard	Senior Vice President of Technical Development & Operations
Mr. Matthew L. Wein J.D.	General Counsel, Compliance Officer, Head of BD&L and Corporate Secretary

FAQs

What is Metagenomi, Inc. Common Stock share price today?

Metagenomi, Inc. Common Stock share price today is $1.5 as on April 25, 2026 at 1:29 am IST at the close of the market. Metagenomi, Inc. Common Stock share today touched a day high of $1.5 and a low of $1.42.

What is the 52 week high and 52 week low for Metagenomi, Inc. Common Stock share?

Metagenomi, Inc. Common Stock share touched a 52 week high of $3.95 on October 16, 2025 and a 52 week low of $1.25 on March 30, 2026. Metagenomi, Inc. Common Stock stock price today i.e. April 25, 2026 at 1:29 am IST is closed at $1.5,which is 62.03% down from its 52 week high and 20.00% up from its 52 week low.

What is Metagenomi, Inc. Common Stock's market capitalisation today?

Metagenomi, Inc. Common Stock market capitalisation is $0.00T as on April 25, 2026 at 1:29 am IST.

How to invest in Metagenomi, Inc. Common Stock Stock (MGX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Metagenomi, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Metagenomi, Inc. Common Stock Shares that will get you 1.0000 shares as per Metagenomi, Inc. Common Stock share price of $1.5 per share as on April 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Metagenomi, Inc. Common Stock Stock (MGX) from India?

Indian investors can start investing in Metagenomi, Inc. Common Stock (MGX) shares with as little as ₹94.22 or $1 (as of April 26, 2026 at 12:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹942.20 in Metagenomi, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on April 26, 2026 at 12:44 pm IST). Based on Metagenomi, Inc. Common Stock share’s latest price of $1.5 as on April 25, 2026 at 1:29 am IST, you will get 6.6667 shares of Metagenomi, Inc. Common Stock. Learn more about fractional shares .